Wave Life Sciences (WVE)See Remarks sold ~$1.12M
Chris Francis, See Remarks at Wave Life Sciences, sold ~$1.12M of Wave Life Sciences shares.
- ~$1.12M
- Approx. value · 80K sh @ $14.00
- Traded
- Oct 16, 2024
- Filed
- Oct 19, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 27, 2024Insider10% owner purchased ~$22.3M of WVE shares in the open market
- Oct 16, 2024 · this disclosureInsiderOfficer sold ~$1.12M of WVE shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Wave Life Sciences
OQRO holds no insider, Congress, fund or contract record for Wave Life Sciences dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its WVE page.
Other recent filings by Chris Francis, See Remarks
- SEC Form 4 at Wave Life Sciences (WVE)Nov 14, 2024
- SEC Form 4 at Wave Life Sciences (WVE)Oct 19, 2024
- SEC Form 4 at Wave Life Sciences (WVE)Oct 19, 2024
- SEC Form 4 at Wave Life Sciences (WVE)Oct 19, 2024
The full history of Chris Francis, See Remarks is on the profile page.
How this filing works
Other disclosures at Wave Life Sciences
- SEC Form 4Aug 27, 2025
- SEC Form 4Aug 27, 2025
- SEC Form 4Aug 20, 2025
- SEC Form 4Aug 14, 2025
- SEC Form 4Aug 8, 2025
- SEC Form 4Aug 8, 2025
Everything OQRO holds on this company is on its WVE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
